1. Opioids prescribing restrictions and homelessness: Evidence from hydrocodone rescheduling. (2024). Lozano-Rojas, Felipe ; Olvera, Johabed G ; Gupta, Sumedha ; Ramos, Julio A.
   In: Journal of Housing Economics.
   RePEc:eee:jhouse:v:66:y:2024:i:c:s1051137724000299.

   Full description at Econpapers || Download paper

1. Aliprantis, D., Fee, K., and Schweitzer, M. E. (2019). Opioids and the Labor Market. Working Papers 201807R2, Federal Reserve Bank of Cleveland.
   Paper not yet in RePEc: Add citation now
   

2. Alpert, A. E., Evans, W. N., Lieber, E. M., and Powell, D. (2019). Origins of the opioid crisis and its enduring impacts. Technical report, National Bureau of Economic Research.

3. Alpert, A., Powell, D., and Pacula, R. L. (2018). Supply-side drug policy in the presence of substitutes: Evidence from the introduction of abuse-deterrent opioids. American Economic Journal: Economic Policy, 10(4):1–35.

4. Autor, D. H., Dorn, D., and Hanson, G. H. (2013). The China Syndrome: Local Labor Market Effects of Import Competition in the United States. American Economic Review, 103(6):2121– 2168.

5. Beheshti, D. (2019). Adverse health effects of abuse-deterrent opioids: Evidence from the reformulation of oxycontin. Health economics, 28(12):1449–1461.

6. Buchmueller, T. C. and Carey, C. (2018). The Effect of Prescription Drug Monitoring Programs on Opioid Utilization in Medicare. American Economic Journal: Economic Policy, 10(1):77–112.

7. Charles, K. K., Hurst, E., and Notowidigdo, M. J. (2016). The masking of the decline in manufacturing employment by the housing bubble. Journal of Economic Perspectives, 30(2):179–200.

8. Charles, K. K., Hurst, E., and Schwartz, M. (2018). The Transformation of Manufacturing and the Decline in U.S. Employment. Working Papers 2018-028, Human Capital and Economic Opportunity Working Group.
   Paper not yet in RePEc: Add citation now
   
9. Cho, D., Garcia, D. I., Montes, J., and Weingarden, A. E. (2021). Labor Market Effects of the Oxycodone-Heroin Epidemic. Finance and Economics Discussion Series 2021-025, Board of Governors of the Federal Reserve System (U.S.). Cicero, T. J. and Ellis, M. S. (2015). Abuse-Deterrent Formulations and the Prescription Opioid Abuse Epidemic in the United States: Lessons Learned From OxyContin. JAMA Psychiatry, 72(5):424–430.
   Paper not yet in RePEc: Add citation now
   
10. Cicero, T. J., Ellis, M. S., and Surratt, H. L. (2012). Effect of abuse-deterrent formulation of oxycontin. New England Journal of Medicine, 367(2):187–189.
    Paper not yet in RePEc: Add citation now
    
11. Cicero, T. J., Ellis, M. S., Surratt, H. L., and Kurtz, S. P. (2013). Factors influencing the selection of hydrocodone and oxycodone as primary opioids in substance abusers seeking treatment in the United States. Pain, 154(12):2639–2648.
    Paper not yet in RePEc: Add citation now
    
12. Cicero, T. J., Inciardi, J. A., and Muñoz, A. (2005). Trends in abuse of oxycontin and other opioid analgesics in the united states: 2002-2004. The Journal of Pain, 6(10):662–672.
    Paper not yet in RePEc: Add citation now
    
13. Colón, H. M., Robles, R. R., and Sahai, H. (2001). The validity of drug use responses in a household survey in Puerto Rico: comparison of survey responses of cocaine and heroin use with hair tests.
    Paper not yet in RePEc: Add citation now
    
14. Cone, E. J., Fant, R. V., Rohay, J. M., Caplan, Y. H., Ballina, M., Reder, R. F., Spyker, D., and Haddox, J. D. (2003). Oxycodone involvement in drug abuse deaths: a dawn-based classification scheme applied to an oxycodone postmortem database containing over 1000 cases. Journal of Analytical Toxicology, 27(2):57–67.
    Paper not yet in RePEc: Add citation now
    
15. Cornaggia, K., Hund, J., Nguyen, G., and Ye, Z. (2021). Adolescent OxyContin Abuse. SSRN Electronic Journal.
    Paper not yet in RePEc: Add citation now
    
16. Currie, J., Jin, J., and Schnell, M. (2019). US Employment and Opioids: Is There a Connection? In Polachek, S. W. and Tatsiramos, K., editors, Health and Labor Markets, volume 47 of Research in Labor Economics, pages 253–280. Emerald Publishing Ltd.
    Paper not yet in RePEc: Add citation now
    
17. Custódio, C., Cvijanovic, D., and Wiedemann, M. (2021). Opioid Crisis and Real Estate Prices. SSRN Electronic Journal.
    Paper not yet in RePEc: Add citation now
    
18. Davis, C. S. and Carr, D. H. (2017). Self-regulating profession? administrative discipline of “pill mill” physicians in florida. Substance Abuse, 38(3):265–268. PMID: 28394740.
    Paper not yet in RePEc: Add citation now
    

19. Evans, W. N., Lieber, E. M. J., and Power, P. (2019). How the Reformulation of OxyContin Ignited the Heroin Epidemic. The Review of Economics and Statistics, 101(1):1–15.

20. Grecu, A. M., Dave, D. M., and Saffer, H. (2019). Mandatory Access Prescription Drug Monitoring Programs and Prescription Drug Abuse. Journal of Policy Analysis and Management, 38(1):181– 209.

21. Harrell, A. (1997). The validity of self-reported drug use data: the accuracy of responses on confidential self-administered answered sheets. NIDA research monograph, 167:37–58.
    Paper not yet in RePEc: Add citation now
    

22. Harris, M. C., Kessler, L. M., Murray, M. N., and Glenn, B. (2020). Prescription Opioids and Labor Market Pains: The Effect of Schedule II Opioids on Labor Force Participation and Unemployment.

23. Hays, L. R. (2004). A profile of oxycontin addiction. Journal of Addictive Diseases, 23(4):1–9. PMID: 15339710.
    Paper not yet in RePEc: Add citation now
    
24. Heins, S. E., Buttorff, C., Armstrong, C., and Pacula, R. L. (2021). Claims-Based Measures of Prescription Opioid Utilization: A Practical Guide for Researchers. Drug and Alcohol Dependence.
    Paper not yet in RePEc: Add citation now
    

25. Horwitz, J., Davis, C. S., McClelland, L. S., Fordon, R. S., and Meara, E. (2018). The Problem of Data Quality in Analyses of Opioid Regulation: The Case of Prescription Drug Monitoring Programs. NBER Working Papers 24947, National Bureau of Economic Research, Inc.

26. Howes, C. (2020). Why Does Structural Change Accelerate in Recessions? The Credit Reallocation Channel. Research Working Paper RWP 20-17, Federal Reserve Bank of Kansas City.

27. Jansen, M. (2021). Spillover Effects of the Opioid Epidemic on Consumer Finance. Technical report, Western Finance Association Annual Meeting Paper.
    Paper not yet in RePEc: Add citation now
    

28. Krueger, A. B. (2017). Where Have All the Workers Gone? An Inquiry into the Decline of the U.S. Labor Force Participation Rate. Brookings Papers on Economic Activity, 48(2 (Fall)):1–87.

29. Li, W. and Zhu, Q. (2019). The Opioid Epidemic and Local Public Financing: Evidence from Municipal Bonds. SSRN Electronic Journal.
    Paper not yet in RePEc: Add citation now
    
30. Maestas, N. and Sherry, T. B. (2020). Opioid Treatment for Pain and Worker and Disability Outcomes: Evidence from Health Care Providers’ Prescribing Patterns. NBERl.
    Paper not yet in RePEc: Add citation now
    
31. Meara, E., Horwitz, J. R., Powell, W., McClelland, L., Zhou, W., O’malley, A. J., and Morden, N. E. (2016). State legal restrictions and prescription-opioid use among disabled adults. New England Journal of Medicine, 375(1):44–53.
    Paper not yet in RePEc: Add citation now
    
32. Morral, A. R., McCaffrey, D., and Iguchi, M. Y. (2000). Hardcore drug users claim to be occasional users: drug use frequency underreporting. Drug and Alcohol Dependence, 57(3):193–202.
    Paper not yet in RePEc: Add citation now
    
33. Ouimet, P., Simintzi, E., and Ye, K. (2021). The Impact of the Opioid Crisis on Firm Value and Investment. SSRN Electronic Journal.
    Paper not yet in RePEc: Add citation now
    

34. Park, S. and Powell, D. (2021). Is the Rise in Illicit Opioids Affecting Labor Supply and Disability Claiming Rates? Journal of Health Economics, 76.

35. Pierce, J. R. and Schott, P. K. (2016). The surprisingly swift decline of us manufacturing employment.

36. Powell, D. (2021). The Labor Supply Consequences of the Opioid Crisis. Technical Report WRA1484 -1, RAND Working Paper Series.
    Paper not yet in RePEc: Add citation now
    

37. Powell, D. and Pacula, R. L. (2021). The Evolving Consequences of OxyContin Reformulation on Drug Overdoses. American Journal of Health Economics, 7(1):41–67.

38. Rietveld, C. A. and Patel, P. C. (2020). Prescription opioids and new business establishments. Small Business Economics, pages 1–25.
    Paper not yet in RePEc: Add citation now
    

39. Sacks, D. W., Hollingsworth, A., Nguyen, T. D., and Simon, K. I. (2019). Can Policy Affect Initiation of Addictive Substance Use? Evidence from Opioid Prescribing. NBER Working Papers 25974, National Bureau of Economic Research, Inc.

40. Severtson, S. G., Bartelson, B. B., Davis, J. M., Muñoz, A., Schneider, M. F., Chilcoat, H., Coplan, P. M., Surratt, H., and Dart, R. C. (2013a). Reduced abuse, therapeutic errors, and diversion following reformulation of extended-release oxycodone in 2010. The Journal of Pain, 14(10):1122–1130.
    Paper not yet in RePEc: Add citation now
    
41. Severtson, S. G., Bartelson, B. B., Davis, J. M., Muñoz, A., Schneider, M. F., Chilcoat, H., Coplan, P. M., Surratt, H., and Dart, R. C. (2013b). Reduced abuse, therapeutic errors, and diversion following reformulation of extended-release oxycodone in 2010. The journal of pain, 14(10):1122–1130.
    Paper not yet in RePEc: Add citation now
    
42. Surrat, H. L., O’Grady, C., Kurtz, S. P., Stivers, Y., Cicero, T. J., Dart, R. C., and Chen, M. (2013). Reductions in prescription opioid diversion following recent legislative interventions in Florida. Pharmacoepidemeology and Drug Safety, 23(3):314–320.
    Paper not yet in RePEc: Add citation now
    
43. Temple, J. (2015). American pain: How a young felon and his ring of doctors unleashed America’s deadliest drug epidemic. Rowman & Littlefield.
    Paper not yet in RePEc: Add citation now
    
44. Weeks, E. and Sanford, P. (2019). Financial Impact of the Opioid Crisis on Local Government: Quantifying Costs for Litigation and Policymaking. Kansas Law Review, 67.
    Paper not yet in RePEc: Add citation now
    
45. Wen, H., Hockenberry, J. M., Jeng, P. J., and Bao, Y. (2019). Prescription Drug Monitoring Program Mandates: Impact On Opioid Prescribing And Related Hospital Use. Health Affairs, 38(9):1550–1556.
    Paper not yet in RePEc: Add citation now
    
46. Wightman, R., Perrone, J., Portelli, I., and Nelson, L. (2012). Likeability and abuse liability of commonly prescribed opioids. Journal of Medical Toxicology, 8(4):335–340.
    Paper not yet in RePEc: Add citation now
    

1. Why higher copayments for opioids did not reduce use among Medicare beneficiaries. (2024). Kaestner, Robert ; Joyce, Geoffrey ; Zhou, BO.
   In: Health Economics.
   RePEc:wly:hlthec:v:33:y:2024:i:3:p:466-481.

   Full description at Econpapers || Download paper

2. The cost of influence: How gifts to physicians shape prescriptions and drug costs. (2024). Valente, Marica ; Newham, Melissa.
   In: Journal of Health Economics.
   RePEc:eee:jhecon:v:95:y:2024:i:c:s0167629624000328.

   Full description at Econpapers || Download paper

3. Health Crisis and Housing Market Effects - Evidence from the U.S. Opioid Epidemic. (2023). Dlima, Walter ; Thibodeau, Mark.
   In: The Journal of Real Estate Finance and Economics.
   RePEc:kap:jrefec:v:67:y:2023:i:4:d:10.1007_s11146-021-09884-8.

   Full description at Econpapers || Download paper

4. The Cost of Influence:How Gifts to Physicians Shape Prescriptions and Drug Costs. (2023). Valente, Marica ; Newham, Melissa.
   In: Working Papers.
   RePEc:inn:wpaper:2023-03.

   Full description at Econpapers || Download paper

5. The Cost of Influence: How Gifts to Physicians Shape Prescriptions and Drug Costs. (2023). Valente, Marica ; Newham, Melissa.
   In: Papers.
   RePEc:arx:papers:2203.01778.

   Full description at Econpapers || Download paper

6. Prescription Limiting Laws Effects on Opioid Misuse in the United States. (2023). Chowdhury, Sulin.
   In: 2024 Annual Meeting, July 28-30, New Orleans, LA.
   RePEc:ags:aaea22:335457.

   Full description at Econpapers || Download paper

7. Demographic and Geographic Variation in Fatal Drug Overdoses in the United States, 1999€“2020. (2022). Monnat, Shannon M.
   In: The ANNALS of the American Academy of Political and Social Science.
   RePEc:sae:anname:v:703:y:2022:i:1:p:50-78.

   Full description at Econpapers || Download paper

8. Behavioral Responses to Supply-Side Drug Policy During the Opioid Epidemic. (2022). Liebert, Helge ; Sherry, Tisamarie B ; Balestra, Simone ; Maestas, Nicole.
   In: IZA Discussion Papers.
   RePEc:iza:izadps:dp15221.

   Full description at Econpapers || Download paper

9. Choices and Implications when Measuring the Local Supply of Prescription Opioids. (2022). Cho, David ; Montes, Joshua ; Mezza, Alvaro.
   In: Finance and Economics Discussion Series.
   RePEc:fip:fedgfe:2022-78.

   Full description at Econpapers || Download paper

10. Information shocks and pharmaceutical firms’ marketing efforts: Evidence from the Chantix black box warning removal. (2022). Skira, Meghan ; Lawler, Emily C.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:81:y:2022:i:c:s0167629621001429.

    Full description at Econpapers || Download paper

11. Mortality during resource booms and busts. (2022). Hill, Elaine ; Boslett, Andrew.
    In: Journal of Environmental Economics and Management.
    RePEc:eee:jeeman:v:115:y:2022:i:c:s0095069622000614.

    Full description at Econpapers || Download paper

12. Behavioral Responses to Supply-Side Drug Policy During the Opioid Epidemic. (2022). Liebert, Helge ; Sherry, Tisamarie B ; Balestra, Simone ; Maestas, Nicole.
    In: CESifo Working Paper Series.
    RePEc:ces:ceswps:_9704.

    Full description at Econpapers || Download paper

13. The effect of medical cannabis laws on pharmaceutical marketing to physicians. (2021). Smith, Rhet ; Lebesmuehlbacher, Thomas.
    In: Health Economics.
    RePEc:wly:hlthec:v:30:y:2021:i:10:p:2409-2436.

    Full description at Econpapers || Download paper

14. The Opioid Epidemic: Causes and Consequences. (2021). Barone, Victoria ; Cabrales, Carolina Arteaga.
    In: Working Papers.
    RePEc:tor:tecipa:tecipa-698.

    Full description at Econpapers || Download paper

15. Behavioral Responses to Supply-Side Drug Policy During the Opioid Epidemic. (2021). Liebert, Helge ; Sherry, Tisamarie B ; Balestra, Simone ; Maestas, Nicole.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:29596.

    Full description at Econpapers || Download paper

16. Labor Market Effects of the Oxycodone-Heroin Epidemic. (2021). Garcia, Daniel ; Cho, David ; Weingarden, Alison E.
    In: Finance and Economics Discussion Series.
    RePEc:fip:fedgfe:2021-25.

    Full description at Econpapers || Download paper

17. Drug firms’ payments and physicians’ prescribing behavior in Medicare Part D. (2021). Lieber, Ethan ; Miller, Sarah ; Carey, Colleen.
    In: Journal of Public Economics.
    RePEc:eee:pubeco:v:197:y:2021:i:c:s0047272721000384.

    Full description at Econpapers || Download paper

18. Is the rise in illicit opioids affecting labor supply and disability claiming rates?. (2021). Powell, David ; Park, Sujeong.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:76:y:2021:i:c:s0167629621000151.

    Full description at Econpapers || Download paper

19. Can electronic prescribing mandates reduce opioid-related overdoses?. (2021). Powell, David ; Abouk, Rahi.
    In: Economics & Human Biology.
    RePEc:eee:ehbiol:v:42:y:2021:i:c:s1570677x21000241.

    Full description at Econpapers || Download paper

20. When Innovation Goes Wrong: Technological Regress and the Opioid Epidemic. (2021). Glaeser, Edward L ; Cutler, David M.
    In: Journal of Economic Perspectives.
    RePEc:aea:jecper:v:35:y:2021:i:4:p:171-96.

    Full description at Econpapers || Download paper

21. Opium Price Shocks and Prescription Opioids in the US. (2020). Nisticò, Roberto ; Giua, Ludovica ; Deiana, C.
    In: Health, Econometrics and Data Group (HEDG) Working Papers.
    RePEc:yor:hectdg:20/23.

    Full description at Econpapers || Download paper

22. The Opioid Epidemic Was Not Primarily Caused by Economic Distress But by Other Factors that Can be More Readily Addressed. (2020). Schwandt, Hannes ; Currie, Janet.
    In: Working Papers.
    RePEc:pri:econom:2020-25.

    Full description at Econpapers || Download paper

23. Burdens, Sludge, Ordeals, Red Tape, Oh My! A User’s Guide to the Study of Frictions. (2020). Mikkelsen, Kim Sass ; Madsen, Jonas Krogh ; Moynihan, Donald.
    In: SocArXiv.
    RePEc:osf:socarx:qfykb.

    Full description at Econpapers || Download paper

24. Is the Rise in Illicit Opioids Affecting Labor Supply and Disability Claiming Rates?. (2020). Powell, David ; Park, Sujeong.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:27804.

    Full description at Econpapers || Download paper

25. The Opioid Epidemic Was Not Caused by Economic Distress But by Factors that Could be More Rapidly Addressed. (2020). Schwandt, Hannes ; Currie, Janet.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:27544.

    Full description at Econpapers || Download paper

26. The Evolving Consequences of OxyContin Reformulation on Drug Overdoses. (2020). Powell, David ; Pacula, Rosalie.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:26988.

    Full description at Econpapers || Download paper

27. Drug Firms Payments and Physicians Prescribing Behavior in Medicare Part D. (2020). Miller, Sarah ; Lieber, Ethan ; Carey, Colleen.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:26751.

    Full description at Econpapers || Download paper

28. Retail Pharmacies and Drug Diversion during the Opioid Epidemic. (2020). Zhang, Xuan ; Janssen, Aljoscha.
    In: Working Paper Series.
    RePEc:hhs:iuiwop:1373.

    Full description at Econpapers || Download paper

29. The relationship of opioid prescriptions and the educational performance of children. (2020). Ozturk, Orgul ; Gordanier, John M ; Cotti, Chad D.
    In: Social Science & Medicine.
    RePEc:eee:socmed:v:265:y:2020:i:c:s0277953620306250.

    Full description at Econpapers || Download paper

30. The Economics behind the Epidemic: Afghan Opium Price and Prescription Opioids in the US. (2019). Nisticò, Roberto ; Giua, Ludovica ; Nistico, Roberto ; Deiana, Claudio.
    In: IZA Discussion Papers.
    RePEc:iza:izadps:dp12872.

    Full description at Econpapers || Download paper

Report date: 2025-10-02 21:23:38 || Missing content? Let us know